Your browser doesn't support javascript.
loading
Niacin restriction with NAMPT-inhibition is synthetic lethal to neuroendocrine carcinoma.
Nomura, Miyuki; Ohuchi, Mai; Sakamoto, Yoshimi; Kudo, Kei; Yaku, Keisuke; Soga, Tomoyoshi; Sugiura, Yuki; Morita, Mami; Hayashi, Kayoko; Miyahara, Shuko; Sato, Taku; Yamashita, Yoji; Ito, Shigemi; Kikuchi, Naohiko; Sato, Ikuro; Saito, Rintaro; Yaegashi, Nobuo; Fukuhara, Tatsuro; Yamada, Hidekazu; Shima, Hiroshi; Nakayama, Keiichi I; Hirao, Atsushi; Kawasaki, Kenta; Arai, Yoichi; Akamatsu, Shusuke; Tanuma, Sei-Ichi; Sato, Toshiro; Nakagawa, Takashi; Tanuma, Nobuhiro.
Afiliação
  • Nomura M; Division of Cancer Chemotherapy, Miyagi Cancer Center Research Institute, Natori, Japan.
  • Ohuchi M; Division of Cancer Chemotherapy, Miyagi Cancer Center Research Institute, Natori, Japan.
  • Sakamoto Y; Division of Cancer Chemotherapy, Miyagi Cancer Center Research Institute, Natori, Japan.
  • Kudo K; Division of Cancer Chemotherapy, Miyagi Cancer Center Research Institute, Natori, Japan.
  • Yaku K; Department of Biochemical Oncology, Tohoku University Graduate School of Medicine, Sendai, Japan.
  • Soga T; Department of Obstetrics and Gynecology, Tohoku University Graduate School of Medicine, Sendai, Japan.
  • Sugiura Y; Department of Molecular and Medical Pharmacology, Faculty of Medicine, University of Toyama, Toyama, Japan.
  • Morita M; Institute for Advanced Biosciences, Keio University, Tsuruoka, Japan.
  • Hayashi K; Center for Cancer Immunotherapy and Immunobiology, Kyoto University Graduate School of Medicine, Kyoto, Japan.
  • Miyahara S; Division of Cancer Chemotherapy, Miyagi Cancer Center Research Institute, Natori, Japan.
  • Sato T; Division of Cancer Chemotherapy, Miyagi Cancer Center Research Institute, Natori, Japan.
  • Yamashita Y; Division of Cancer Chemotherapy, Miyagi Cancer Center Research Institute, Natori, Japan.
  • Ito S; Department of Biochemical Oncology, Tohoku University Graduate School of Medicine, Sendai, Japan.
  • Kikuchi N; Department of Obstetrics and Gynecology, Tohoku University Graduate School of Medicine, Sendai, Japan.
  • Sato I; Division of Cancer Chemotherapy, Miyagi Cancer Center Research Institute, Natori, Japan.
  • Saito R; Division of Cancer Chemotherapy, Miyagi Cancer Center Research Institute, Natori, Japan.
  • Yaegashi N; Division of Cancer Chemotherapy, Miyagi Cancer Center Research Institute, Natori, Japan.
  • Fukuhara T; Division of Cancer Chemotherapy, Miyagi Cancer Center Research Institute, Natori, Japan.
  • Yamada H; Department of Pathology, Miyagi Cancer Center Hospital, Natori, Japan.
  • Shima H; Institute for Advanced Biosciences, Keio University, Tsuruoka, Japan.
  • Nakayama KI; Department of Obstetrics and Gynecology, Tohoku University Graduate School of Medicine, Sendai, Japan.
  • Hirao A; Department of Respiratory Medicine, Miyagi Cancer Center Hospital, Natori, Japan.
  • Kawasaki K; Division of Cancer Chemotherapy, Miyagi Cancer Center Research Institute, Natori, Japan.
  • Arai Y; Division of Cancer Chemotherapy, Miyagi Cancer Center Research Institute, Natori, Japan.
  • Akamatsu S; Department of Molecular and Cellular Biology, Medical Institute of Bioregulation, Kyusyu University, Fukuoka, Japan.
  • Tanuma SI; TMDU Advanced Research Institute, Tokyo Medical and Dental University, Tokyo, Japan.
  • Sato T; Division of Molecular Genetics, Cancer and Stem Cell Research Program, Cancer Research Institute and WPI Nano Life Science Institute, Kanazawa University, Kanazawa, Japan.
  • Nakagawa T; Department of Organoid Medicine, Keio University School of Medicine, Tokyo, Japan.
  • Tanuma N; Department of Urology, Miyagi Cancer Center Hospital, Natori, Japan.
Nat Commun ; 14(1): 8095, 2023 Dec 13.
Article em En | MEDLINE | ID: mdl-38092728
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Carcinoma Neuroendócrino / Niacina Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Carcinoma Neuroendócrino / Niacina Idioma: En Ano de publicação: 2023 Tipo de documento: Article